WallStreetZenWallStreetZen

NASDAQ: LTRN
Lantern Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LTRN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$16.0M
Current Profit Margin
0%

LTRN Return on Equity

Current Company
-34.1%
Current Industry
-63.5%
Current Market
188%
LTRN's Return on Equity (-34.1%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LTRN announces earnings.

LTRN Return on Assets

Current Company
-32.2%
Current Industry
2.9%
LTRN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LTRN Return on Capital Employed

Current Company
-38.96%
Current Industry
19.5%
LTRN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LTRN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LTRN$0.00-$15.79M-$15.96MN/AN/A
KRON$6.29M-$107.76M-$112.67MN/AN/A
CDTX$63.91M-$21.21M-$22.93M+32.21%N/A
CELU$14.79M-$169.66M-$181.41M-81.46%N/A
MURA$0.00-$192.72M-$207.45MN/AN/A
View Top Biotech Stocks

LTRN earnings dates

Next earnings date
Jun 14, 2024

Lantern Pharma Earnings & Revenue FAQ

What were LTRN's earnings last quarter?

On Invalid Date, Lantern Pharma (NASDAQ: LTRN) reported Q4 2023 earnings per share (EPS) of -$0.39, up 25.81% year over year. Total Lantern Pharma earnings for the quarter were -$4.19 million. In the same quarter last year, Lantern Pharma's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Lantern Pharma stock.

What was LTRN's earnings growth in the past year?

As of Q2 2024, Lantern Pharma's earnings has grown year over year. Lantern Pharma's earnings in the past year totalled -$15.96 million.

What is LTRN's earnings date?

Lantern Pharma's earnings date is Invalid Date. Add LTRN to your watchlist to be reminded of LTRN's next earnings announcement.

What was LTRN's revenue last quarter?

On Invalid Date, Lantern Pharma (NASDAQ: LTRN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Lantern Pharma's revenue was $0.00.

What was LTRN's revenue growth in the past year?

As of Q2 2024, Lantern Pharma's revenue has grown null year over year. Lantern Pharma's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.